Wuhan Humanwell Innovative Drug Research And Development Center Limited Company
Clinical trials sponsored by Wuhan Humanwell Innovative Drug Research And Development Center Limited Company, explained in plain language.
-
New shot HWS116 takes on advanced cancers in early trial
Disease control Recruiting nowThis early-stage study tests a new drug called HWS116 in about 56 adults with advanced solid tumors (like colorectal, gastric, or pancreatic cancer) that have stopped responding to standard treatments. The main goals are to check safety and find the right dose, and to see if the …
Phase: PHASE1 • Sponsor: Wuhan Humanwell Innovative Drug Research and Development Center Limited Company • Aim: Disease control
Last updated May 26, 2026 08:31 UTC
-
New drug HW071021 enters first human tests for advanced cancers
Disease control Recruiting nowThis early-stage trial tests a new drug called HW071021 in 76 adults with advanced solid tumors (cancers that have spread or come back). The main goal is to check the drug's safety and find the best dose. Researchers will also look at how the drug moves through the body and wheth…
Phase: PHASE1 • Sponsor: Wuhan Humanwell Innovative Drug Research and Development Center Limited Company • Aim: Disease control
Last updated May 26, 2026 08:30 UTC
-
New IBD drug candidate begins first human safety tests
Knowledge-focused Recruiting nowThis early-stage study tests an experimental drug called HW201877 in 104 healthy adults to see if it is safe and how the body handles it. The drug is being developed for inflammatory bowel disease (IBD). Participants will receive either the drug or a placebo, and researchers will…
Phase: PHASE1 • Sponsor: Wuhan Humanwell Innovative Drug Research and Development Center Limited Company • Aim: Knowledge-focused
Last updated May 26, 2026 08:31 UTC